NIH ENERGY ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.0% 2.0% 2.0% 2.0% 2.0%  
Bankruptcy risk  4.0% 3.2% 4.5% 3.6% 4.3%  
Credit score (0-100)  51 55 45 52 47  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  565 917 606 401 258  
EBITDA  166 309 46.2 297 125  
EBIT  156 265 6.7 257 85.8  
Pre-tax profit (PTP)  149.3 350.2 160.6 252.2 88.7  
Net earnings  118.0 279.3 121.3 187.4 68.8  
Pre-tax profit without non-rec. items  149 350 161 252 88.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  395 351 312 272 233  
Shareholders equity total  392 671 793 380 449  
Interest-bearing liabilities  197 158 417 29.5 13.3  
Balance sheet total (assets)  957 1,550 1,585 778 710  

Net Debt  -318 -285 257 -161 -95.4  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  565 917 606 401 258  
Gross profit growth  -5.3% 62.1% -33.9% -33.9% -35.5%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  957 1,550 1,585 778 710  
Balance sheet change%  139.3% 61.9% 2.2% -50.9% -8.8%  
Added value  165.6 309.3 46.2 296.7 125.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  377 -88 -79 -79 -79  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  27.5% 28.9% 1.1% 64.2% 33.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  26.6% 29.0% 10.8% 22.2% 12.3%  
ROI %  40.7% 49.2% 16.0% 29.7% 17.6%  
ROE %  35.4% 52.5% 16.6% 32.0% 16.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  41.0% 43.3% 50.0% 48.9% 63.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -191.9% -92.1% 555.4% -54.2% -76.1%  
Gearing %  50.2% 23.5% 52.6% 7.8% 3.0%  
Net interest  0 0 0 0 0  
Financing costs %  31.8% 7.4% 2.9% 4.4% 11.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.6 1.6 0.4 1.9 2.4  
Current Ratio  1.6 1.6 0.4 1.9 2.4  
Cash and cash equivalent  514.7 442.7 160.0 190.3 108.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  92.6 258.4 -414.3 238.5 275.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 309 46 297 125  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 309 46 297 125  
EBIT / employee  0 265 7 257 86  
Net earnings / employee  0 279 121 187 69